CRL vs LVS · rev $2.00B vs P/E 28, rev $6.74B
Charles River Laboratories (CRL) versus Las Vegas Sands Corp (LVS) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported LVS revenue for 2026-06-30 was $6.74B. Net income was $913.0M. Revenue was up 88.0% from 2026-03-31 to 2026-06-30. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
CRL currently screens at market cap $7.78B. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Not investment advice. Open the CRL and LVS stock pages for the full models.
Not investment advice.